2-(furan-2-yl)-5-(piperidin-3-yl)-1,3,4-oxadiazole, 95.0%, 250mg

1-(4-Chlorophenyl)-5-methyl-1h-pyrazole-3-carboxylic acid, 95+%, 100mg

(R)-1-O-TOLYLETHANAMINE, 95.0%, 100mg

4-Chloro-6-nitroquinoline, 95.0%, 1g

(1Z)-N'-Hydroxy-2-(4-methyl-1-piperazinyl)ethaneimidamide, 95.0%, 1g

(E)-4,4'-(Diazene-1,2-diyl)bis(2-methylbenzoic acid), 98%, 100mg

Methyl 2-(3-oxo-2-pentylcyclopentyl)acetate, 95.0%, 25g

5-(Dihydrofuran-2(3H)-ylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione, 95+%, 1g

rSRL-LecBeads [for GlcNAc beta(1-2)Man, Gal beta(1-3)GalNAc]1vial

4-(2-Bromoethyl)pyridine hydrobromide, 97.0%, 1g

2-(3,5-DIMETHYLPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE, 95.0%, 5g

tert-Butyl (S)-(1-Amino-3-phenyl-1-thioxopropan-2-yl)carbamate, 95%, 250mg

2,2'-Bipyridine-4,4'-dicarboxylic Acid>96.0%(HPLC)(T)1g